|
[Related PubMed/MEDLINE]
Total Number of Papers: 540
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: EIAV |
| Long Form |
: equine infectious anemia virus |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Serological evidence of circulation of West Nile virus in equids in Algerian eastern drylands and its epidemiological risk factors. |
USUV, VNT, WNV |
| 2 |
2022 |
A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element. |
CRM1, RRE |
| 3 |
2022 |
Coupling spatial statistics with social network analysis to estimate distinct risk areas of disease circulation to improve risk-based surveillance. |
--- |
| 4 |
2022 |
Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus. |
aa, BiFC, Co-IP, CRM1, RRE, RT-PCR |
| 5 |
2022 |
Low transmission rates of Equine infectious anemia virus (EIAV) in foals born to seropositive feral mares inhabiting the Amazon delta region despite climatic conditions supporting high insect vector populations. |
AGID |
| 6 |
2022 |
MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation. |
HIV-1, MLV |
| 7 |
2022 |
Serological cross-sectional survey of equine infectious anemia in Saudi Arabia. |
EIA |
| 8 |
2022 |
SYNJ2BP Improves the Production of Lentiviral Envelope Protein by Facilitating the Formation of Mitochondrion-Associated Endoplasmic Reticulum Membrane. |
ER, ERAD, MAM |
| 9 |
2022 |
The Emerging Role of the Serine Incorporator Protein Family in Regulating Viral Infection. |
HBV, HIV, MLV, SERINC |
| 10 |
2021 |
Effect of Small Polyanions on In Vitro Assembly of Selected Members of Alpha-, Beta- and Gammaretroviruses. |
MLV, MPMV, RSV |
| 11 |
2021 |
Equine Infectious Anemia Virus (EIAV): Evidence of Circulation in Donkeys from the Brazilian Northeast Region. |
AGID, EIA, ELISA, OIE, PCR, rgp90, rp26 |
| 12 |
2021 |
Identification and genetic characterization of equine infectious anemia virus in Western Balkans. |
AGID, EIA, ELISA |
| 13 |
2021 |
Impact of changes of horse movement regulations on the risks of equine infectious anemia: A risk assessment approach. |
--- |
| 14 |
2021 |
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity. |
A-MLV, HIV-1, IAV, MLV, MPMV, PIV5, RABV, VSV-G |
| 15 |
2021 |
Modelling Mutation in Equine Infectious Anemia Virus Infection Suggests a Path to Viral Clearance with Repeated Vaccination. |
--- |
| 16 |
2021 |
Molecular detection of equine infectious anemia virus in clinically normal, seronegative horses in an endemic area of Mexico. |
AGID, EIA |
| 17 |
2021 |
Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization. |
CT, CTs, Env, Envs, PM, SU, TM |
| 18 |
2020 |
A Conserved Acidic-Cluster Motif in SERINC5 Confers Partial Resistance to Antagonism by HIV-1 Nef. |
glycoGag, HIV-1, MLV |
| 19 |
2020 |
Comparative analysis of CpG islands in equine infectious anemia virus strains. |
--- |
| 20 |
2020 |
Equine lentivirus counteracts SAMHD1 restriction by Rev-mediated degradation of SAMHD1 via the BECN1-dependent lysosomal pathway. |
BECN1 |
| 21 |
2020 |
High Genomic Variability in Equine Infectious Anemia Virus Obtained from Naturally Infected Horses in Pantanal, Brazil: An Endemic Region Case. |
EIA, NGS |
| 22 |
2020 |
Identification of large genetic variations in the equine infectious anemia virus tat-gag genomic region. |
AGID, EIA, ELISAs, tat-gag |
| 23 |
2020 |
Molecular Characterization of the Major Open Reading Frames (ORFs) and Enhancer Elements From Four Geographically Distinct North American Equine Infectious Anemia Virus (EIAV) Isolates. |
EIAVPA, LTRs, ORFs, ORFs |
| 24 |
2020 |
Molecular detection, histopathological analysis, and immunohistochemical characterization of equine infectious anemia virus in naturally infected equids. |
EIA |
| 25 |
2020 |
SERINC5 Potently Restricts Retrovirus Infection In Vivo. |
glycoGag, HIV, HIV-1, MLV, mSERINC5, SERINC |
| 26 |
2020 |
Structures of immature EIAV Gag lattices reveal a conserved role for IP6 in lentivirus assembly. |
CA, VLPs |
| 27 |
2019 |
A PLPPV sequence in the p8 region of Gag provides late domain function for mouse mammary tumor virus. |
MMTV |
| 28 |
2019 |
Attenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to Apoptosis. |
eMDMs |
| 29 |
2019 |
Characterization of EIAV env Quasispecies during Long-Term Passage In Vitro: Gradual Loss of Pathogenicity. |
SGA |
| 30 |
2019 |
HIV Vaccine Mystery and Viral Shell Disorder. |
HCV, HIV, HSV |
| 31 |
2019 |
Molecular characterization of equine infectious anaemia virus strains detected in England in 2010 and 2012. |
--- |
| 32 |
2019 |
Molecular characterization of Equine Infectious Anemia Viruses using targeted sequence enrichment and next generation sequencing. |
--- |
| 33 |
2019 |
Surveillance of the equine infectious anemia virus in Eastern and Central Saudi Arabia during 2014-2016. |
KSA |
| 34 |
2019 |
The Conserved Tyr176/Leu177 Motif in the alpha-Helix 9 of the Feline Immunodeficiency Virus Capsid Protein Is Critical for Gag Particle Assembly. |
CA, FIV |
| 35 |
2019 |
The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5. |
BiFC, eSERINC5, IP, MLV, SERINC5 |
| 36 |
2019 |
Thermostable properties of the equine infectious anemia virus nucleocapsid protein NCp11. |
NC |
| 37 |
2018 |
Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo. |
EHR, LTR, NRE, TAR, TSS |
| 38 |
2018 |
Equine infectious anemia virus in naturally infected horses from the Brazilian Pantanal. |
AGID, EIA, snPCR |
| 39 |
2018 |
Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV). |
eMX2, hMXB |
| 40 |
2018 |
Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein. |
eMDMs, eqMx2, HIV-1, IFN, MLV, SIVs |
| 41 |
2018 |
Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses. |
BIV, PAMPs, PRRs, SRLV |
| 42 |
2018 |
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists. |
HIV, MLV, SERINC3, VSV-G |
| 43 |
2017 |
Clues for two-step virion infectivity factor regulation by core binding factor beta. |
CBFbeta, SIVmac, Vif |
| 44 |
2017 |
Covalent conjugation of the equine infectious anemia virus Gag with SUMO. |
SUMO |
| 45 |
2017 |
Deep sequencing and variant analysis of an Italian pathogenic field strain of equine infectious anaemia virus. |
NGS, ORFs |
| 46 |
2017 |
Detection of West Nile Virus and other common equine viruses in three locations from the Leeward Islands, West Indies. |
EI, EVA, WNV |
| 47 |
2017 |
Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses. |
SCID |
| 48 |
2017 |
Equine infectious anemia prevalence in feral donkeys from Northeast Brazil. |
IB |
| 49 |
2017 |
Molecular characterization of bovine leukemia virus from Moldovan dairy cattle. |
BLV, EBL, HIV |
| 50 |
2017 |
Molecular characterization of equine infectious anaemia virus from a major outbreak in southeastern France. |
EIA |
| 51 |
2017 |
Nonsynonymous changes of equine lentivirus receptor-1 (ELR1) gene in amino acids involved in the interaction with equine infectious anemia virus (EIAV). |
ELR1, SNPs, TNFRSF14 |
| 52 |
2017 |
The integration of a macrophage-adapted live vaccine strain of equine infectious anaemia virus (EIAV) in the horse genome. |
FED, GO, IS, KEGG, LINEs, MDMs, RefSeq |
| 53 |
2016 |
A pilot study on interaction between donkey tetherin and EIAV stains with different virulent and replication characteristics. |
do-tetherin, Env |
| 54 |
2016 |
Comparison of Antibody Immune responses to different HIV-1 Envelope Glycoprotein Mutants. |
HIV-1 |
| 55 |
2016 |
Double-stranded-RNA-specific adenosine deaminase 1 (ADAR1) is proposed to contribute to the adaptation of equine infectious anemia virus from horses to donkeys. |
EIA |
| 56 |
2016 |
Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism. |
eSLFN11, RSCU |
| 57 |
2016 |
Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins. |
MLVs |
| 58 |
2016 |
Genetic Evolution during the development of an attenuated EIAV vaccine. |
--- |
| 59 |
2016 |
Health and epidemiological approaches of Trypanosoma evansi and equine infectious anemia virus in naturally infected horses at southern Pantanal. |
--- |
| 60 |
2016 |
Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN. |
IN, LTR, SU |
| 61 |
2016 |
Identification and characterization of a common B-cell epitope on EIAV capsid proteins. |
AC-ELISA, mAbs |
| 62 |
2016 |
Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response. |
--- |
| 63 |
2016 |
Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study. |
AE, GEM, nvAMD, TU |
| 64 |
2016 |
Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease. |
LV, PD |
| 65 |
2016 |
Regulation of Rev expression by the equine infectious anaemia virus tat-rev mRNA Kozak sequence and its potential influence on viral replication. |
--- |
| 66 |
2016 |
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3. |
AP2, Nef, SERINC |
| 67 |
2016 |
Serologically silent, occult equine infectious anemia virus (EIAV) infections in horses. |
OIE |
| 68 |
2016 |
Structural and functional characterization of EIAV gp45 fusion peptide proximal region and asparagine-rich layer. |
FPPR, HIV |
| 69 |
2015 |
ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interaction. |
EGFR, ESCRT, MVB |
| 70 |
2015 |
Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome. |
FED, HIV, LINEs, SINEs, TSS |
| 71 |
2015 |
Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity. |
ADARs, eADAR1, HIV, LTR, RRE |
| 72 |
2015 |
Equine Infectious Anemia Virus Gag Assembly and Export Are Directed by Matrix Protein through trans-Golgi Networks and Cellular Vesicles. |
MA, PM, TGN |
| 73 |
2015 |
Free-virus and cell-to-cell transmission in models of equine infectious anemia virus infection. |
IFE, ODEs |
| 74 |
2015 |
Freedom from equine infectious anaemia virus infection in Spanish Purebred horses. |
EIA, SP |
| 75 |
2015 |
Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45. |
--- |
| 76 |
2015 |
Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection. |
eCT1, ELR1, eTat, LTR, MEFs, RT-PCR, TNFR |
| 77 |
2015 |
Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus. |
HIV, KEGG, PRM, SIV |
| 78 |
2015 |
Structural insight into equine lentivirus receptor 1. |
AUC, CRD1, ELR1, ITC |
| 79 |
2015 |
The efficacy of ELISA commercial kits for the screening of equine infectious anemia virus infection. |
--- |
| 80 |
2014 |
A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses. |
--- |
| 81 |
2014 |
Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey. |
--- |
| 82 |
2014 |
Comparative analysis of LTR and structural genes in an equine infectious anemia virus strain isolated from a feral horse in Japan. |
LTRs |
| 83 |
2014 |
Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding. |
RRE |
| 84 |
2014 |
Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation. |
BIV, CAEV, CBF-beta, FIV, MVV, Vif |
| 85 |
2014 |
Development of antigencapture ELISA for the quantification of EIAV p26 protein. |
AC-ELISA, HRP, mAbs, RT, WB |
| 86 |
2014 |
Development, evaluation, and laboratory validation of immunoassays for the diagnosis of equine infectious anemia (EIA) using recombinant protein produced from a synthetic p26 gene of EIA virus. |
AGID, EIA, ELISA |
| 87 |
2014 |
Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility. |
--- |
| 88 |
2014 |
Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum. |
eMDMs, ER, eViperin, SAM |
| 89 |
2014 |
Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses. |
ERV, FFV, MLV |
| 90 |
2014 |
High genetic diversity of equine infectious anaemia virus strains from Slovenia revealed upon phylogenetic analysis of the p15 gag gene region. |
--- |
| 91 |
2014 |
Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus. |
SCID |
| 92 |
2014 |
Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain. |
EMDM, IFNbeta, TLR3 |
| 93 |
2014 |
Prevalence of antibodies against influenza virus in non-vaccinated equines from the Brazilian Pantanal. |
EIV |
| 94 |
2014 |
Serosurveillance of infectious agents in equines of the Central Valley of Costa Rica. |
EVAV, IAV, WNV |
| 95 |
2014 |
Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain. |
HIV |
| 96 |
2014 |
Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin. |
--- |
| 97 |
2014 |
The dUTPase-related gene of bovine immunodeficiency virus is critical for viral replication, despite the lack of dUTPase activity of the encoded protein. |
BIV, dUTPases, WT |
| 98 |
2014 |
Use of heavy water (D2O) in developing thermostable recombinant p26 protein based enzyme-linked immunosorbent assay for serodiagnosis of equine infectious anemia virus infection. |
ELISA |
| 99 |
2013 |
Amplification of complete gag gene sequences from geographically distinct equine infectious anemia virus isolates. |
--- |
| 100 |
2013 |
Comprehensive analysis of the overall codon usage patterns in equine infectious anemia virus. |
CAI, ENC |
|
A Search Service for Abbreviation / Long Form
